|
DOJ Inspecting Novartis, Specialty Pharmacy Arrangement
The DOJ is looking into Novartis’ relationship with Accredo Health Group, handing the specialty pharmacy company a subpoena on dealings related to iron overload drug Exjade (deferasirox).
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives